Effects of proangiotensin-12 infused continuously over 14 days in conscious rats

European Journal of Pharmacology

Volumn 683, Issue 1-3, 2012, Pages 186-189

  Komatsu, Yoichi ^a,b,c   Kida, Nobuaki ^b   Nozaki, Naomi ^b   Kuwasako, Kenji ^b   Nagata, Sayaka ^c   Kitamura, Kazuo ^c   Kato, Johji ^b  

^a MINAMI KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Losartan; Perindopril; Proangiotensin 12; Prolonged infusion

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; LOSARTAN; PERINDOPRIL; PROANGIOTENSIN 12; UNCLASSIFIED DRUG;

ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONSCIOUSNESS; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ALDOSTERONE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIOMEGALY; HEART; HYPERTENSION; INFUSIONS, SUBCUTANEOUS; MALE; MYOCARDIUM; ORGAN SIZE; PEPTIDE FRAGMENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS; VASOCONSTRICTOR AGENTS; WEIGHT GAIN;

EID: 84860488872     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.02.037     Document Type: Article

References (22)

1. S. Ahmad, J. Varagic, B.M. Westwood, M.C. Chappell, and C.M. Ferrario Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes PLoS One 6 2011 e15759
2. A.C. Arnold, K. Isa, H.A. Shaltout, M. Nautiyal, C.M. Ferrario, M.C. Chappell, and D.I. Diz Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus Am. J. Physiol. Heart Circ. Physiol. 299 2010 H763 H771
3. B. Bujak-Gizycka, R. Olszanecki, M. Suski, J. Madej, A. Stachowicz, and R. Korbut Angiotensinogen metabolism in rat aorta: robust formation of proangiotensin-12 J. Physiol. Pharmacol. 61 2010 679 682
4. D.J. Campbell Circulating and tissue angiotensin systems J. Clin. Invest. 79 1987 1 6
5. M.C. Chappell, B.M. Westwood, K.D. Pendergrass, J. Jessup, and C.M. Ferrario Distinct processing pathways for the novel peptide angiotensin-(1-12) in the serum and kidney of the hypertensive mRen2.Lewis rat (Abstract) Hypertension 50 2007 e139
6. A.W. Cowley, and J.W. DeClue Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs Circ. Res. 39 1976 779 787
7. B.F. Cox, and V.S. Bishop Neural and humoral mechanisms of angiotensin-dependent hypertension Am. J. Physiol. Heart Circ. Physiol. 261 1991 H1284 H1291
8. E.G. Erdös Angiotensin I converting enzyme and the changes in our concepts through the years Hypertension 16 1990 363 370
9. C.M. Ferrario, J. Varagic, J. Habibi, S. Nagata, J. Kato, M.C. Chappell, A.J. Trask, K. Kitamura, A. Whaley-Connell, and J.R. Sowers Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1184 H1192
10. J.A. Jessup, A.J. Trask, M.C. Chappell, S. Nagata, J. Kato, K. Kitamura, and C.M. Ferrario Localization of the novel angiotensin peptide, angiotensin-(1-12), in heart and kidney of hypertensive and normotensive rats Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2614 H2618
11. H. Kobori, M. Nangaku, L.G. Navar, and A. Nishiyama The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease Pharmacol. Rev. 59 2007 251 287
12. Q. Li, W.E. Dale, E.M. Hasser, and E.H. Blaine Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency Am. J. Physiol. Regul. Integr. Comp. Physiol. 271 1996 R200 R207
13. S. Nagata, J. Kato, K. Sasaki, N. Minamino, T. Eto, and K. Kitamura Isolation and identification of proangiotensin-12, a possible component of the renin-angiotensin system Biochem. Biophys. Res. Commun. 350 2006 1026 1031
14. S. Nagata, J. Kato, K. Kuwasako, and K. Kitamura Plasma and tissue levels of proangiotensin-12 and components of the renin-angiotensin system (RAS) following low- or high-salt feeding in rats Peptides 31 2010 889 892
15. S. Oparil, S.A. Yarows, S. Patel, H. Fang, J. Zhang, and A. Satlin Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial Lancet 370 9583 2007 221 229
16. H.C. Prosser, M.E. Forster, A.M. Richards, and C.J. Pemberton Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics Cardiovasc. Res. 82 2009 40 50
17. H.C. Prosser, A.M. Richards, M.E. Forster, and C.J. Pemberton Regional vascular response to ProAngiotensin-12 (PA12) through the rat arterial system Peptides 31 2010 1540 1545
18. A.J. Trask, J.A. Jessup, M.C. Chappell, and C.M. Ferrario Angiotensin-(1-12) is an alternate substrate for angiotensin peptide production in the heart Am. J. Physiol. Heart Circ. Physiol. 294 2008 H2242 H2247
19. T. Tsuruda, J. Kato, K. Hatakeyama, H. Masuyama, Y.N. Cao, T. Imamura, K. Kitamura, Y. Asada, and T. Eto Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats Cardiovasc. Res. 65 2005 921 929
20. H. Urata, and D. Ganten Cardiac angiotensin II formation: the angiotensin-I converting enzyme and human chymase Eur. Heart J. 14 Suppl. I 1993 177 182
21. H. Urata, H. Nishimura, and D. Ganten Chymase-dependent angiotensin II forming systems in humans Am. J. Hypertens. 9 1996 277 284
22. J. Varagic, A.J. Trask, J.A. Jessup, M.C. Chappell, and C.M. Ferrario New angiotensins J. Mol. Med. (Berl) 86 2008 663 671